Harshal J. Desai

FDA investigator

Appears on 6 documents from 2022 to 2024, mostly at sites in Florida. Most often cites written procedures; deviations (21 CFR 211.100(a)).

6
Documents on file
4.5
Observations per 483
2022
First seen
2024
Most recent

What they cite most

From 27 observations

Activity by year

2022: 3, 2023: 2, 2024: 1

Where

Florida 3 · North Carolina 2 · South Carolina 1

Often inspects with

Jared P. Stevens

Is Harshal J. Desai coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

6 documents, newest first
FirmOpen
483 Active Intelligence, LLCMar 8, 2024 · Cherryville, North Carolina
483 Balassa Laboratories Inc.Apr 7, 2023 · Port Orange, Florida
483 The Procter & Gamble Manufacturing CompanyMar 10, 2023 · Greensboro, North Carolina
483 Dextrum Laboratories IncDec 16, 2022 · Miami, Florida
483 Profounda IncAug 9, 2022 · Orlando, Florida
483 Royal Labs Natural Cosmetics, Inc.Jun 30, 2022 · Johns Island, South Carolina

About this profile

What does Harshal J. Desai inspect?

Harshal J. Desai appears on 6 documents on file covering 6 sites, mostly in Florida.

What do they cite most often?

21 CFR 211.100(a) (written procedures; deviations), followed by 21 CFR 211.166(a) and 21 CFR 211.80(b).

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Harshal J. Desai is dated Mar 8, 2024.